Hyperthyroidism Flashcards
causes of hyperthyroidism
graves’ disease, TSH-secreting pituitary adenomas, toxic adenoma
graves’ disease is an
autoimmune syndrome that may include hyperthyroidism, diffuse thyroid enlargement, exophthalmos, pretibial myxedema, thyroid acropachy
in graves’ disease
thyroid stimulating immunoglobulin functions as an agonist at the TSH receptor, stimulating hormone production and release
Graves’s disease patients will have antibodies to
TPO
about 15% of graves’ patients will
spontaneously develop Hashimoto’s
TSH-secreting pituitary adenomas
release of biologically active hormone that is unresponsive to normal feedback control and occurs sporadically
toxic adenoma
autonomous thyroid nodule, seen as “hot: nodules on radioiodine scan
hyperthyroidism lab values
elevated free and total T3 and T4 with a low TSH and elevated RAIU
increased RAIU indicates
indicated true hyperthyroidism
decreased RAIU indicates that
the excess thyroid hormone is not a consequence of thyroid gland hyperfunction
thioamides
methimazole and propylthiouracil
methimazole
inhibits thyroid peroxidase (T4/T3 synthesis)
propylthiouracil
inhibits thyroid peroxidase, and inhibits 5’ deiodinase
half life of MMI
5 hours
half life of PTU
1 hour
duration of action of MMI
24 hours
duration of action of PTU
6-10 hours
metabolic clearance of MMI and PTU
decreased in renal and hepatic disease
MMI vs. PTU
MMI is 10-12 times more potent than PTU
MMI contraindications
pregnancy and breastfeeding
PTU contraindications
pregnancy
drug interactions of thioamides
warfarin - by correcting the underlying hyperthyroidism, metabolism of clotting factors will be reduced resulting in decreased response to warfarin
pregnancy and thioamides
PTU has historically been the preferred agent if treatment is necessary
thioamides - minor adverse effects
fever, rash, arthralgias, transient leucopenia
thioamides - major adverse effects
agranulocytosis, hepatitis, vasculitis, lupus-like syndrome
PTU initial dose
300-600mg divided three to four times daily
PTU maintenance dose
50-300mg divided two to three times daily
PTU max dose
1200 mg/day
MMI initial dose
30-60mg divided three times daily
MMI maintenance dose
5-30mg daily